首页> 外文期刊>Molecular & cellular proteomics: MCP >Identification of Salivary Biomarkers for Oral Cancer Detection with Untargeted and Targeted Quantitative Proteomics Approaches
【24h】

Identification of Salivary Biomarkers for Oral Cancer Detection with Untargeted and Targeted Quantitative Proteomics Approaches

机译:用未明确和靶向定量蛋白质组学方法鉴定口腔癌检测的唾液生物标志物

获取原文
获取原文并翻译 | 示例
           

摘要

Oral cavity squamous cell carcinoma (OSCC) is one of the most common cancers worldwide. In Taiwan, OSCC is the fifth leading cause of cancer-related mortality and leads to 2800 deaths per year. The poor outcome of OSCC patients is principally ascribed to the fact that this disease is often advanced at the time of diagnosis, suggesting that early detection of OSCC is urgently needed. Analysis of cancer-related body fluids is one promising approach to identify biomarker candidates of cancers. To identify OSCC biomarkers, salivary proteomes of OSCC patients, individuals with oral potentially malignant disorders (OPMDs), and healthy volunteers were comparatively profiled with isobaric tags for relative and absolute quantitation (iTRAQ)-based mass spectrometry (MS). The salivary levels of 67 and 18 proteins in the OSCC group are elevated and decreased compared with that in the noncancerous group (OPMD and healthy groups), respectively. The candidate biomarkers were further selected using the multiple reaction monitoring (MRM)-MS and validated with the immunoassays. More importantly, the higher salivary level of three proteins, complement factor H (CFH), fibrinogen alpha chain (FGA), and alpha-1-antitrypsin (SERPINA1) was correlated with advanced stages of OSCC. Our results indicate that analysis of salivary proteome is a feasible strategy for biomarker discovery, and the three proteins are potential salivary markers for OSCC diagnosis.
机译:口腔鳞状细胞癌(OSCC)是全球最常见的癌症之一。在台湾,OSCC是癌症相关死亡率的第五个主要原因,每年导致2800人死亡。 OSCC患者的良差结果主要归因于诊断时这种疾病往往是先进的事实,这表明迫切需要早期检测OSCC。癌症相关的体液分析是一种鉴定癌症的生物标志物候选的一种有希望的方法。为了鉴定OSCC生物标志物,OSCC患者的唾液蛋白质组织,具有口腔潜在恶性疾病(OPMDS)的个体,以及健康志愿者的同伴具有相对定量(ITRAQ)的异质谱(ITRAQ)的异质谱(MS)相对突出。与非癌变基团(OPMD和健康组)相比,OSCC组67和18蛋白的唾液水平升高并降低。使用多重反应监测(MRM)-MS进一步选择候选生物标志物并用免疫测定验证。更重要的是,三种蛋白质,补体系数H(CFH),纤维蛋白原α链(FGA)和α-1-抗酸型(Serpina1)的较高唾液酸级水平与OSCC的晚期阶段相关。我们的研究结果表明,唾液蛋白质组分析是生物标志物发现的可行策略,三种蛋白质是OSCC诊断的潜在唾液标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号